JT
RLAY icon

Jupiter Topco’s Relay Therapeutics RLAY Stock Holding History

Jupiter Topco’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$866K Buy
+46,273
New +$672K ﹤0.01% 1856

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco's RLAY Position: Q2 2026 in Review

Jupiter Topco opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 46,273 shares worth $866K. The stake represents ﹤0.01% of the portfolio and ranks #1856 among its holdings.

241 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Jupiter Topco held 46,273 shares of Relay Therapeutics worth $866K as of Q2 2026.
  • Relay Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1856 holding.
  • 241 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.